Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
RATIONALE: Understanding the emotional needs of spouses or others who are living with and caring for patients who have undergone stem cell transplantation may help improve the quality of life of both the caregivers and the patients.
PURPOSE: This clinical trial is studying the emotional needs of caregivers of patients who have undergone stem cell transplant.
Chronic Myeloproliferative Disorders
Gestational Trophoblastic Tumor
Multiple Myeloma and Plasma Cell Neoplasm
Psychosocial Effects of Cancer and Its Treatment
Testicular Germ Cell Tumor
Procedure: psychosocial assessment and care
|Official Title:||Emotional Needs of Caregivers and Patient/Spouse Couples During Hematopoietic Stem Cell Transplantation (HSCT)|
|Study Start Date:||March 2002|
|Study Completion Date:||October 2004|
|Primary Completion Date:||October 2004 (Final data collection date for primary outcome measure)|
- Assess expression of emotion, as a function of patient presence, among spousal or other cohabiting caregivers (CG) of post-hematopoietic stem cell transplantation patients.
- Assess desynchrony among subjective (self-report) and expressive indicators of emotion, as a function of patient presence, in these participants.
- Correlate CG dispositional inhibition and desynchrony with physical and marital satisfaction in these participants.
OUTLINE: Caregivers (CG) complete written questionnaires assessing demographics, positive and negative affect, dispositional inhibition, marital satisfaction, and physical health over 45 minutes to 1 hour on day 1. CG then engage in two oral emotional expression exercises (on the topic of caregiving and the transplant) over 2 hours on day 2. Patients are present for one oral emotional expression exercise.
Participants are followed at 2 weeks and 6 months.
PROJECTED ACCRUAL: A total of 60 patient/spouse couples will be accrued for this study within 18 months.
|United States, Washington|
|Fred Hutchinson Cancer Research Center|
|Seattle, Washington, United States, 98109-1024|
|Principal Investigator:||Shelby Langer, PhD||Fred Hutchinson Cancer Research Center|